Martin Shkreli** is an American former pharmaceutical executive and entrepreneur, best known for his controversial actions in the pharmaceutical industry and his involvement in legal issues. He gained widespread notoriety in 2015 when, as the CEO of **Turing Pharmaceuticals**, he raised the price of the life-saving drug **Daraprim** by over 5,000%, from $13.50 to $750 per pill. This move sparked widespread outrage and led to Shkreli being labeled as "the most hated man in America" by some media outlets.

### Key Highlights of Martin Shkreli's Career:

1. **Turing Pharmaceuticals**:
- Shkreli became the CEO of **Turing Pharmaceuticals** in 2015 and made headlines for dramatically increasing the price of Daraprim, a drug used to treat **toxoplasmosis**, a parasitic infection that can be fatal to individuals with weakened immune systems, such as those with HIV/AIDS.
- The price hike led to public backlash from politicians, healthcare professionals, and the general public, with many accusing Shkreli of price gouging and unethical business practices.

2. **Pharmaceutical Industry Background**:
- Before Turing Pharmaceuticals, Shkreli worked at other pharmaceutical companies, including **Retrophin**, which he co-founded in 2011. Retrophin was focused on developing treatments for rare diseases.
- Shkreli was ousted from Retrophin in 2014 after a series of legal disputes and accusations of misconduct, including allegations that he misappropriated company funds.

3. **Legal Issues and Conviction**:
- In 2017, Martin Shkreli was convicted on **charges of securities fraud and conspiracy** related to his actions while running Retrophin. Specifically, he was accused of misleading investors and manipulating stock prices.
- He was sentenced to **seven years in prison** for his role in the fraud scheme. Additionally, he was ordered to forfeit $7.4 million in assets and pay a fine.
- Shkreli's conviction did not directly relate to his actions at Turing Pharmaceuticals, but his time in the spotlight due to the Daraprim price hike was a key aspect of his public persona.

4. **Media and Public Persona**:
- Shkreli's controversial actions and outspoken nature made him a frequent subject of media attention. His smug demeanor and provocative comments, including offering a **$5,000 reward for a strand of Hillary Clinton's hair** in 2016, made him a target for criticism.
- He was also known for his activity on social media, where he often engaged with critics in a combative manner.

5. **Post-Prison**:
- After his release from prison in 2022, Shkreli has kept a relatively low profile, although he has occasionally made public statements on various issues, including his views on cryptocurrency and the pharmaceutical industry.

### Legacy and Impact:
Martin Shkreli's legacy is largely defined by the public outrage caused by his actions in the pharmaceutical industry and his subsequent legal troubles. His price hike of Daraprim and his controversial behavior have made him a symbol of corporate greed in the healthcare sector. While he did contribute to the development of treatments for rare diseases, his reputation remains tarnished due to his unethical business practices and legal issues.

Knowledwge Source Credit: @VentureCoinist

Full Podcast: [ Ссылка ]

We repurpose podcast clips to add value and share meaningful insights with audience. If you own the content and have any concerns or issues regarding the use of your video clips,

please feel free to contact us for content removal request at teamsavansojitra@gmail.com

We are committed to addressing your concerns promptly and respectfully.

свернуть